首页|雷公藤多苷治疗糖尿病肾病1例及抗炎抗纤维化疗效分析

雷公藤多苷治疗糖尿病肾病1例及抗炎抗纤维化疗效分析

One case of diabetic nephropathy treated with multi-glycosides of tripterygium wilfordii and efficacy analysis of its anti-inflammatory and anti-fibrosis

扫码查看
糖尿病肾脏疾病(DN)是最令人担忧的糖尿病慢性微血管并发症之一,也是终末期肾病(ESRD)的主要原因.对DN患者积极干预,完善饮食、运动、血糖、血压等基础治疗的情况下,肾脏特异性药物对DN患者仍有良好获益.特别是中国传统医学药物,在现代医药工艺下形成中成药物,以雷公藤多苷(GTW)、百令胶囊等为代表.临床上合理选择和使用中成药物是DN治疗的重要方法之一.本文报道1例GTW治疗DN患者,以进一步提高临床医师对该病和GTW的认识.
Diabetic nephropathy(DN)is one of the most worrisome chronic microvascular complications of diabetes and a leading cause of end-stage renal disease(ESRD).In the case of aggressive intervention in patients with DN and im-provement of basic treatment such as diet,exercise,blood glucose,blood pressure,kidney-specific drugs still have good benefits for DN patients.In particular,traditional Chinese medicines,Chinese medicines formed under modem medical technology,represented by multi-glycosides of tripterygium wilfordii(GTW),Bailing Capsules,etc.Clinically rational selection and use of Chinese medicines is one of the important methods for the treatment of DN.This paper reports a case analysis of DN treated with GTW,aiming to improve the understanding of the disease and GTW.

Diabetic nephropathyMulti-glycosides of tripterygium wilfordiiAnti-inflammatoryAnti-fibrosis

李温柳、邢春燕、李勤、赵咏莉、何春玲、王李卓、高家林

展开 >

皖南医学院弋矶山医院内分泌科,安徽芜湖 241000

糖尿病肾病 雷公藤多苷 抗炎 抗纤维化

安徽省自然科学基金

2108085MH267

2024

中华全科医学
中华预防医学会,安徽省全科医学会

中华全科医学

CSTPCD
影响因子:1.688
ISSN:1674-4152
年,卷(期):2024.22(3)
  • 17